{"entity":{"type":"insider","cik":"0001253598","url":"/insider/0001253598","json_url":"/insider/0001253598.json","name":"SFM PARTICIPATION LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":102,"n_filings":16,"first":"2004-01-05","last":"2010-03-10","span_basis":"filed_date"},"name_variants":[{"name":"SFM PARTICIPATION LP","source":"filing","n_filings":16,"first_seen":"2004-01-05","last_seen":"2010-03-10"}],"transactions":[{"id":7170722,"accession":"0000950142-10-000405","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950142-10-000405","line_url":"/filing/0000950142-10-000405#line-2","is_derivative":false,"issuer_cik":"0001237655","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001237655","owner_cik":null,"owner_name":"SFM AH LLC; SFM PARTICIPATION LP","owner_display_name":"SFM AH LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":634.0,"shares_display":"634","price_per_share":15.4,"price_display":"15.40","price_state":"stated","total_value":9763.6,"total_display":"9,763.60","total_whole":"9,764","shares_owned_after":2826169.0,"shares_owned_after_display":"2,826,169","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-09","filed_date":"2010-03-10","scope":"insider"},{"id":7170720,"accession":"0000950142-10-000405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-10-000405","line_url":"/filing/0000950142-10-000405#line-1","is_derivative":false,"issuer_cik":"0001237655","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001237655","owner_cik":null,"owner_name":"SFM AH LLC; SFM PARTICIPATION LP","owner_display_name":"SFM AH LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3155.0,"shares_display":"3,155","price_per_share":14.61,"price_display":"14.61","price_state":"stated","total_value":46094.55,"total_display":"46,094.55","total_whole":"46,095","shares_owned_after":2826803.0,"shares_owned_after_display":"2,826,803","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-08","filed_date":"2010-03-10","scope":"insider"},{"id":7399247,"accession":"0000950142-10-000391","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950142-10-000391","line_url":"/filing/0000950142-10-000391","is_derivative":false,"issuer_cik":"0001237655","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001237655","owner_cik":null,"owner_name":"SFM AH LLC; SFM PARTICIPATION LP","owner_display_name":"SFM AH LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32012.0,"shares_display":"32,012","price_per_share":13.95,"price_display":"13.95","price_state":"stated","total_value":446567.4,"total_display":"446,567.40","total_whole":"446,567","shares_owned_after":2829958.0,"shares_owned_after_display":"2,829,958","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-05","filed_date":"2010-03-08","scope":"insider","n_lines":3},{"id":7399238,"accession":"0000950142-10-000391","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950142-10-000391","line_url":"/filing/0000950142-10-000391","is_derivative":false,"issuer_cik":"0001237655","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001237655","owner_cik":null,"owner_name":"SFM AH LLC; SFM PARTICIPATION LP","owner_display_name":"SFM AH LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3835.0,"shares_display":"3,835","price_per_share":14.148482398956975,"price_display":"14.15","price_state":"stated","total_value":54259.43,"total_display":"54,259.43","total_whole":"54,259","shares_owned_after":2861970.0,"shares_owned_after_display":"2,861,970","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-04","filed_date":"2010-03-08","scope":"insider","n_lines":3},{"id":7606789,"accession":"0000950142-07-002391","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950142-07-002391","line_url":"/filing/0000950142-07-002391#line-5","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"Soros Robert; SOROS GEORGE; SOROS FUND MANAGEMENT LLC; PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; PERSEUS SOROS PARTNERS LLC; SFM AH LLC; SFM PARTICIPATION LP; SOROS JONATHAN T ALLAN","owner_display_name":"Soros Robert","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000.0,"shares_display":"175,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2100000.0,"total_display":"2,100,000.00","total_whole":"2,100,000","shares_owned_after":4076170.0,"shares_owned_after_display":"4,076,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-11","filed_date":"2007-10-12","scope":"insider"},{"id":4004799,"accession":"0000950142-06-002315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-06-002315","line_url":"/filing/0000950142-06-002315#line-1","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; SFM PARTICIPATION LP; PEARL FRANK H; SFM AH LLC; SOROS FUND MANAGEMENT LLC; SOROS GEORGE; PERSEUSPUR LLC; PERSEUS SOROS PARTNERS LLC; PERSEUS BIOTECH FUND PARTNERS LLC","owner_display_name":"PERSEUS SOROS BIOPHARMACEUTICAL FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500000.0,"shares_display":"1,500,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":24000000.0,"total_display":"24,000,000.00","total_whole":"24,000,000","shares_owned_after":2377403.0,"shares_owned_after_display":"2,377,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-05","filed_date":"2006-12-07","scope":"insider"},{"id":1310636,"accession":"0000950142-05-003218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-05-003218","line_url":"/filing/0000950142-05-003218#line-1","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"Adams Respiratory Therapeutics, Inc.","issuer_ticker":"ARXT","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"PERSEUS SOROS PARTNERS LLC; PEARL FRANK H; SFM AH LLC; PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; PERSEUSPUR LLC; PERSEUS BIOTECH FUND PARTNERS LLC; SFM PARTICIPATION LP; SOROS FUND MANAGEMENT LLC; SOROS GEORGE","owner_display_name":"PERSEUS SOROS PARTNERS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1715458.0,"shares_display":"1,715,458","price_per_share":43.75,"price_display":"43.75","price_state":"stated","total_value":75051287.5,"total_display":"75,051,287.50","total_whole":"75,051,288","shares_owned_after":3372918.0,"shares_owned_after_display":"3,372,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-14","filed_date":"2005-12-15","scope":"insider"},{"id":1369931,"accession":"0000950142-05-002163","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950142-05-002163","line_url":"/filing/0000950142-05-002163#line-2","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"Adams Respiratory Therapeutics, Inc.","issuer_ticker":"ARXT","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"SFM AH LLC; SOROS FUND MANAGEMENT LLC; PERSEUSPUR LLC; PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; PEARL FRANK H; SOROS GEORGE; PERSEUS BIOTECH FUND PARTNERS LLC","owner_display_name":"SFM AH LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1609000.0,"shares_display":"1,609,000","price_per_share":15.81,"price_display":"15.81","price_state":"stated","total_value":25438290.0,"total_display":"25,438,290.00","total_whole":"25,438,290","shares_owned_after":5088376.0,"shares_owned_after_display":"5,088,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-26","filed_date":"2005-07-28","scope":"insider"},{"id":1460473,"accession":"0000950142-05-001941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-05-001941","line_url":"/filing/0000950142-05-001941#line-1","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"SOROS GEORGE; PERSEUS BIOTECH FUND PARTNERS LLC; SFM PARTICIPATION LP; PERSEUSPUR LLC; SFM AH LLC; SOROS FUND MANAGEMENT LLC; PEARL FRANK H; PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; PERSEUS SOROS PARTNERS LLC","owner_display_name":"SOROS GEORGE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":612089.0,"shares_display":"612,089","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":2999236.1,"total_display":"2,999,236.10","total_whole":"2,999,236","shares_owned_after":3877403.0,"shares_owned_after_display":"3,877,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-30","filed_date":"2005-07-05","scope":"insider"},{"id":1484613,"accession":"0000950142-05-000473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-05-000473","line_url":"/filing/0000950142-05-000473#line-1","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"BARRIER THERAPEUTICS INC","issuer_ticker":"BTRX","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; SFM PARTICIPATION LP; PEARL FRANK H; SFM AH LLC; SOROS FUND MANAGEMENT LLC; SOROS GEORGE; PERSEUSPUR LLC; PERSEUS SOROS PARTNERS LLC; PERSEUS BIOTECH FUND PARTNERS LLC","owner_display_name":"PERSEUS SOROS BIOPHARMACEUTICAL FUND LP","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430004.0,"shares_display":"430,004","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":8385078.0,"total_display":"8,385,078.00","total_whole":"8,385,078","shares_owned_after":2324734.0,"shares_owned_after_display":"2,324,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-15","filed_date":"2005-02-17","scope":"insider"},{"id":532242,"accession":"0000950142-04-004523","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0000950142-04-004523","line_url":"/filing/0000950142-04-004523","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":null,"owner_name":"PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; PERSEUS BIOTECH FUND PARTNERS LLC; SFM AH LLC","owner_display_name":"PERSEUS SOROS PARTNERS LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15342.0,"shares_display":"15,342","price_per_share":8.546086559770565,"price_display":"8.55","price_state":"stated","total_value":131114.06,"total_display":"131,114.06","total_whole":"131,114","shares_owned_after":390264.0,"shares_owned_after_display":"390,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-22","filed_date":"2004-12-23","scope":"insider","n_lines":29},{"id":365656,"accession":"0000950142-04-004512","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000950142-04-004512","line_url":"/filing/0000950142-04-004512#line-14","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":null,"owner_name":"PERSEUS BIOTECH FUND PARTNERS LLC; PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; SFM AH LLC","owner_display_name":"PERSEUS BIOTECH FUND PARTNERS LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21172.0,"shares_display":"21,172","price_per_share":8.4,"price_display":"8.40","price_state":"stated","total_value":177844.8,"total_display":"177,844.80","total_whole":"177,845","shares_owned_after":411037.0,"shares_owned_after_display":"411,037","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-21","filed_date":"2004-12-23","scope":"insider"},{"id":365655,"accession":"0000950142-04-004512","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000950142-04-004512","line_url":"/filing/0000950142-04-004512#line-13","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":null,"owner_name":"PERSEUS BIOTECH FUND PARTNERS LLC; PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; SFM AH LLC","owner_display_name":"PERSEUS BIOTECH FUND PARTNERS LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6464.0,"shares_display":"6,464","price_per_share":8.45,"price_display":"8.45","price_state":"stated","total_value":54620.8,"total_display":"54,620.80","total_whole":"54,621","shares_owned_after":398680.0,"shares_owned_after_display":"398,680","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-21","filed_date":"2004-12-23","scope":"insider"},{"id":365654,"accession":"0000950142-04-004512","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000950142-04-004512","line_url":"/filing/0000950142-04-004512#line-12","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":null,"owner_name":"PERSEUS BIOTECH FUND PARTNERS LLC; PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; SFM AH LLC","owner_display_name":"PERSEUS BIOTECH FUND PARTNERS LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4208.0,"shares_display":"4,208","price_per_share":8.42,"price_display":"8.42","price_state":"stated","total_value":35431.36,"total_display":"35,431.36","total_whole":"35,431","shares_owned_after":406513.0,"shares_owned_after_display":"406,513","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-21","filed_date":"2004-12-23","scope":"insider"},{"id":365653,"accession":"0000950142-04-004512","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000950142-04-004512","line_url":"/filing/0000950142-04-004512#line-11","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":null,"owner_name":"PERSEUS BIOTECH FUND PARTNERS LLC; PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; SFM AH LLC","owner_display_name":"PERSEUS BIOTECH FUND PARTNERS LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3655.0,"shares_display":"3,655","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":31067.5,"total_display":"31,067.50","total_whole":"31,068","shares_owned_after":392186.0,"shares_owned_after_display":"392,186","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-21","filed_date":"2004-12-23","scope":"insider"},{"id":365652,"accession":"0000950142-04-004512","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000950142-04-004512","line_url":"/filing/0000950142-04-004512#line-10","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":null,"owner_name":"PERSEUS BIOTECH FUND PARTNERS LLC; PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; SFM AH LLC","owner_display_name":"PERSEUS BIOTECH FUND PARTNERS LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1730.0,"shares_display":"1,730","price_per_share":8.51,"price_display":"8.51","price_state":"stated","total_value":14722.3,"total_display":"14,722.30","total_whole":"14,722","shares_owned_after":390456.0,"shares_owned_after_display":"390,456","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-21","filed_date":"2004-12-23","scope":"insider"},{"id":365651,"accession":"0000950142-04-004512","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950142-04-004512","line_url":"/filing/0000950142-04-004512#line-9","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":null,"owner_name":"PERSEUS BIOTECH FUND PARTNERS LLC; PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; SFM AH LLC","owner_display_name":"PERSEUS BIOTECH FUND PARTNERS LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1621.0,"shares_display":"1,621","price_per_share":8.46,"price_display":"8.46","price_state":"stated","total_value":13713.66,"total_display":"13,713.66","total_whole":"13,714","shares_owned_after":397059.0,"shares_owned_after_display":"397,059","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-21","filed_date":"2004-12-23","scope":"insider"},{"id":365650,"accession":"0000950142-04-004512","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950142-04-004512","line_url":"/filing/0000950142-04-004512#line-8","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":null,"owner_name":"PERSEUS BIOTECH FUND PARTNERS LLC; PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; SFM AH LLC","owner_display_name":"PERSEUS BIOTECH FUND PARTNERS LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1160.0,"shares_display":"1,160","price_per_share":8.44,"price_display":"8.44","price_state":"stated","total_value":9790.4,"total_display":"9,790.40","total_whole":"9,790","shares_owned_after":405144.0,"shares_owned_after_display":"405,144","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-21","filed_date":"2004-12-23","scope":"insider"}],"collapsed":true,"next_cursor":"2004-12-21|365650","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001401923","name":"MAP Pharmaceuticals, Inc.","url":"/issuer/0001401923","role":"Ten percent owner","n_filings":3,"first_seen":"2007-10-12","last_seen":"2010-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Ten percent owner","n_filings":3,"first_seen":"2004-07-30","last_seen":"2006-12-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001319439","name":"Adams Respiratory Therapeutics, Inc.","url":"/issuer/0001319439","role":"Ten percent owner","n_filings":2,"first_seen":"2005-07-28","last_seen":"2005-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001173657","name":"BARRIER THERAPEUTICS INC","url":"/issuer/0001173657","role":"Other","n_filings":1,"first_seen":"2005-02-17","last_seen":"2005-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001028205","name":"BIOENVISION INC","url":"/issuer/0001028205","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2004-05-17","last_seen":"2004-12-23"},{"type":"issuer","type_label":"ISSUER","cik":"0000932352","name":"VALENTIS INC","url":"/issuer/0000932352","role":"Ten percent owner","n_filings":2,"first_seen":"2004-01-05","last_seen":"2004-02-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001253598","retrieved_at":"2026-08-25T04:12:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}